Notice of Proposed Sale · 144
ODDITY Tech Ltd.
ODDNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- ODDITY TECH LTD
- Issuer CIK
- 0001907085
- SEC file number
- 001-41745
- Phone
- 972525014724
- Person for whose account securities are to be sold
- Lindsay Drucker Mann
- Relationships to issuer
- Officer
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 809 | 11,722.41 | 34,577,554 | 09/03/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 09/03/2026 | Exercise of Stock Options | Issuer | 809 | N | 09/03/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for LINDSAY DRUCKER MANN | Common | 09/01/2026 | 7,717 | 116,431.78 |
| LINDSAY DRUCKER MANN | Common | 08/31/2026 | 12,286 | 175,321.22 |
| 10b5-1 Sales for LINDSAY DRUCKER MANN | Common | 08/28/2026 | 21,571 | 326,533.17 |
| 10b5-1 Sales for LINDSAY DRUCKER MANN | Common | 08/27/2026 | 5,503 | 82,568.11 |
| 10b5-1 Sales for LINDSAY DRUCKER MANN | Common | 08/26/2026 | 3,493 | 52,413.51 |
| LINDSAY DRUCKER MANN | Common | 08/05/2026 | 11,473 | 173,242.30 |
| 10b5-1 Sales for LINDSAY DRUCKER MANN | Common | 06/30/2026 | 100,000 | 1,509,370.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 2, entry 1
- Name
- LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 3, entry 1
- Name
- 10b5-1 Sales for LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 4, entry 1
- Name
- 10b5-1 Sales for LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 5, entry 1
- Name
- 10b5-1 Sales for LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 6, entry 1
- Name
- LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Seller — prior-sale row 7, entry 1
- Name
- 10b5-1 Sales for LINDSAY DRUCKER MANN
- Street
- 8 HaHarash Street
- City
- Tel Aviv-Jaffa
- State / country code
- L3
- Postal code
- 6761304
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 09/03/2026
- Signed
- /s/ Lindsay Drucker Mann
- Plan adoption dates
- 03/13/2026
Company context
ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves over 70 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE, SpoiledChild, and METHODIQ. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.